84
Participants
Start Date
October 31, 2017
Primary Completion Date
November 25, 2019
Study Completion Date
November 25, 2019
Procedure
Serial blood draws. Participants will be enrolled either pre-transplant or within 45 days post-transplant and will be followed over the course of 18 months post transplant. Protocol mandated serial measurement of cytomegalovirus (CMV)-specific immune signature will occur pre-transplant (as applicable) and at post-transplant timepoint months 2, -3, -6, -9, -12 and -18.
Johns Hopkins Hospital: Transplantation, Baltimore
Duke University Medical Center: Transplantation, Durham
Cleveland Clinic Foundation: Transplantation, Cleveland
Toronto General Hospital: Transplantation, Toronto
Clinical Trials in Organ Transplantation
NETWORK
Rho Federal Systems Division, Inc.
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH